A cost effectiveness analysis of low dose computed tomography lung cancer screening has been conducted in the chinese population. The analysis is part of a broader discussion on the cost effectiveness of lung cancer screening, with some studies suggesting it is most beneficial for those at highest risk and others noting that it can be cost effective if done correctly. The specifics of the analysis and its findings are not clear, with various outlets discussing different aspects of lung cancer screening, including the use of artificial intelligence and the challenges of implementation in different regions.